retatrutide phase 2 results obesity nejm 2023 Retatrutide: A Triple Agonist Shaping the Future of Metabolic Care This data from Phase 3

Rival incretin-based therapies from Novo Nordisk, including semaglutide-based blockbusters Ozempic and Wegovy, continue to anchor the market, although Eli Lilly has been taking the edge with its tirzepatide products Mounjaro and Zepbound

Alcohol consumed the evening before a morning dose does not meaningfully affect the next morning absorption

*The recipe makes 2 servings, of protein, and fiber-based on 1 serving Dinner: Turkey Stuffed Bell Peppers (27g protein, 8g fiber*)

Identify the injection area on the middle of the front or outer portion of your thigh (mid-thigh), away from the knee and groin areas

People who want better metabolic health and significant weight loss may like to use it